Beijing: Zhong Shanshan, who has done the business of bottled water in China, has become the richest man of Asia. According to a Bloomberg report, in the past week, Zhong’s total assets have been $ 85 billion. Zhong is originally a business of Nongfu Spring Mineral Water. In addition, his pharma company Sekai Biological Pharmacy manufactures enterprise vaccines. Both these companies were included in China’s stock listing last year.
Zhong Shanshan started a water company named Nongfu Spring in 1996. Today, its value has increased to $ 5.7 billion. Currently, he has become the 17th richest man in the world according to the Bloomberg Billionaires Index. After becoming the richest man in Asia, now Chairman of Reliance Industries Mukesh Ambani has come in second place.
Corona Connection is behind the rise of Zhong Shanshan’s wealth. He developed the vaccine in April from Beijing Wantai Biological Pharmacy Enterprise Co. (Beijing Wantai Biological Pharmacy Enterprise Co.). A few months later, Nongfu Spring Co., which produces bottled water, became one of the most popular in Hong Kong. So this year, his wealth grew strongly. Nongfu shares have jumped 155 per cent since its inception, while Wantai has jumped over 2,000 per cent.
How did Zhong come in business
In this race, Zhong Shanshan has been slightly ahead of Jackma. Jack Ma currently has assets of $ 567 billion. Zhong Shanshan has come from Hongzhou, Zhejiang Province, China. First he worked as a worker in a production company, then he was a reporter in a newspaper and after that he ventured into business.
Pharmaceuticals changed the situation
The wealth of this Chinese industrialist has increased dramatically in recent months. He has since increased his stake in Beijing Vantai Biological Pharmacy Enterprise, a pharmaceutical company. This company was listed in Shanghai in the month of April itself.
Let me tell you that most of China’s billionaires come from the tech industry, but after the increasing tension between China and America on Huawei, Ticketock and WeChat, the difference in the prices of Chinese tech stocks has started to appear.
